273 related articles for article (PubMed ID: 33879171)
21. Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
Wang L; Zhang X; Liu Y; Xu S
J Cell Physiol; 2020 Apr; 235(4):3612-3625. PubMed ID: 31566718
[TBL] [Abstract][Full Text] [Related]
22. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
[TBL] [Abstract][Full Text] [Related]
23. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
24. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
25. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.
Tang J; Meng Q; Shi R; Xu Y
Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431
[TBL] [Abstract][Full Text] [Related]
26. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
27. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
28. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
[TBL] [Abstract][Full Text] [Related]
29. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
Zu Y; Wang D; Ping W; Sun W
Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis.
Wang J; Chen T; Yu X; OUYang N; Tan L; Jia B; Tong J; Li J
J Transl Med; 2020 Aug; 18(1):313. PubMed ID: 32795291
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
34. Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma.
Zhang Q; Shi R; Bai Y; Meng L; Hu J; Zhu H; Liu T; De X; Wang S; Wang J; Xu L; Zhou G; Yin R
Cancer Commun (Lond); 2021 Jun; 41(6):492-510. PubMed ID: 33734616
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
36. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
37. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
38. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
[TBL] [Abstract][Full Text] [Related]
39. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
40. microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma.
Dai B; Kong DL; Tian J; Liu TW; Zhou H; Wang ZF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1125-1133. PubMed ID: 30779081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]